96 related articles for article (PubMed ID: 321366)
41. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. I. Surface markers and K cell activity after separation of B cells and lymphocytes and Fc-receptors by column fractionation.
Pape GR; Troye M; Perlmann P
J Immunol; 1977 Jun; 118(6):1919-24. PubMed ID: 325129
[No Abstract] [Full Text] [Related]
42. T- and B-cells in immunologic diseases.
Strober S
Am J Clin Pathol; 1977 Nov; 68(5 Suppl):671-8. PubMed ID: 335878
[TBL] [Abstract][Full Text] [Related]
43. T-lymphocyte recognition of alloantigen in vitro. I. Significance of Fc-receptor-positive T and B stimulator cell in the generation of cytotoxic T lymphocytes.
Hertel-Wulff B; Rubin B
Scand J Immunol; 1977; 6(9):933-44. PubMed ID: 302982
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of T. lymphocyte functions by Fc fragments of immunoglobulin. II. Augmentation of the cell-mediated lympholysis response occurs through an Lyt-1+2- helper T cell.
Morgan EL; Thoman ML; Weigle WO
J Immunol; 1981 Dec; 127(6):2526-30. PubMed ID: 6457879
[TBL] [Abstract][Full Text] [Related]
45. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
46. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
[TBL] [Abstract][Full Text] [Related]
47. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
Broström H; Troye-Bomberg M; Perlmann P
Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
[TBL] [Abstract][Full Text] [Related]
48. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.
Härfast B; Andersson T; Perlmann P
J Immunol; 1975 Jun; 114(6):1820-3. PubMed ID: 1168673
[TBL] [Abstract][Full Text] [Related]
49. Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations.
Rynnel-Dagöö B; Möller E; Waterfield E
Clin Exp Immunol; 1977 Mar; 27(3):425-31. PubMed ID: 301072
[TBL] [Abstract][Full Text] [Related]
50. Lymphocyte functions and subpopulation distribution in marmosets.
Wallen WC; Claysmith AP; Cicmanec JL
Primates Med; 1978; 10():184-92. PubMed ID: 417319
[TBL] [Abstract][Full Text] [Related]
51. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
Troye M; Pape GR
Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
[TBL] [Abstract][Full Text] [Related]
52. Purification of human peripheral blood colony forming cells (CFUC).
Goldberg J; McGuire LA; Dock NL; Williams WJ; Davey FR
Exp Hematol; 1980 Oct; 8(9):1086-93. PubMed ID: 7014236
[TBL] [Abstract][Full Text] [Related]
53. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
Yu A; Watts H; Jaffe N; Parkman R
N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxic reactivity of human lymphocytes cultured in vitro.
Ortaldo JR; Bonnard GD; Herberman RB
J Immunol; 1977 Oct; 119(4):1351-7. PubMed ID: 894041
[No Abstract] [Full Text] [Related]
55. Reactivity of peripheral blood leukocytes against human foetal cells. II. Cytotoxic potential of preparations enriched or depleted of different leukocyte populations.
Vose BM; Moore M
Int J Cancer; 1977 Jan; 19(1):34-42. PubMed ID: 299854
[TBL] [Abstract][Full Text] [Related]
56. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells.
Saal JG; Rieber EP; Hadam M; Riethmuller G
Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919
[No Abstract] [Full Text] [Related]
57. T lymphocyte induction of non-T cell-mediated nonspecific cytotoxicity. I. Introduction mechanisms.
Mackler BF; O'Neill PA; Meistrich M
Eur J Immunol; 1977 Feb; 7(2):55-61. PubMed ID: 326561
[TBL] [Abstract][Full Text] [Related]
58. Characterization of mononuclear effector cells in human blood.
Hersey P; Edwards A; Edwards J
Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
[TBL] [Abstract][Full Text] [Related]
59. Contribution of lymphocytes bearing Fcgamma receptors to PHA-induced cytotoxicity.
Cordier G; Samarut C; Revillard JP
Immunology; 1978 Jul; 35(1):49-56. PubMed ID: 308041
[TBL] [Abstract][Full Text] [Related]
60. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
